CBD side effects: liver, medicines and who should avoid it

26/09/2026
Stainless-steel processing equipment with filtration units in a Formula Swiss laboratory

Yes, CBD can cause side effects, though most are mild and linked to dose. The most common in clinical trials, mainly at prescription doses of 10–25 mg per kg a day, are sleepiness, diarrhoea, reduced appetite and tiredness. At higher doses CBD can raise liver enzymes, and it can change how some medicines work. Pregnant or breastfeeding women, people under 18 and anyone taking medication should avoid CBD or ask a doctor first.

Key facts

Most common side effects
Sleepiness, diarrhoea, reduced appetite and tiredness (prescription CBD trials)
Most important risk
Raised liver enzymes, mainly at high doses and together with certain medicines
Medicines
CBD can raise or lower blood levels of some medicines. Ask your doctor or pharmacist first.
Who should avoid it
Pregnancy, breastfeeding, trying to conceive, under 18s and people on medication (UK FSA). EFSA says safety can't be established for under 25s.
EU reference amount (EFSA, 2026)
About 2 mg of CBD a day for a 70 kg adult, for pure CBD in food supplements. No CBD food is authorised in the EU yet; Formula Swiss is a co-founder of the EIHA consortium that is seeking authorisation.
UK reference amount (FSA)
Healthy adults: no more than 10 mg of CBD a day from food
Long-term safety
Trials so far last weeks to months; long-term data are still being collected

Is CBD oil safe?

In clinical trials CBD was generally well tolerated, but it is not free of risk. Most of what we know comes from trials of a prescription epilepsy medicine, at doses far higher than a typical food supplement. Those trials show that side effects become more likely as the dose goes up, and that the liver and other medicines are the main concerns.

The World Health Organization's expert committee concluded in 2018 that CBD "is generally well tolerated with a good safety profile" and that in humans it "exhibits no effects indicative of any abuse or dependence potential" (WHO Expert Committee on Drug Dependence, 2018).

Food regulators have therefore set cautious reference amounts, well below the trial doses.

What are the common side effects of CBD oil?

The best data come from the controlled trials behind Epidyolex, the prescription CBD medicine approved in the EU for three rare forms of epilepsy that usually begin in childhood. At 10–25 mg of CBD per kg of body weight a day, the most common side effects were:

  • Sleepiness or sedation (23%)
  • Reduced appetite (21%)
  • Diarrhoea (20%)
  • Fever (16%), vomiting (12%) and tiredness (10%)

Rash and irritability were less frequent. Many effects depended on the dose and were more frequent with other epilepsy medicines. Sleepiness, for example, affected 43% of patients who also took clobazam, against 14% of those who did not (EMA, Epidyolex product information).

A 2020 review of 12 placebo-controlled trials (803 participants) came to a similar view. Outside the childhood epilepsy studies, diarrhoea was the only side effect clearly linked to CBD. The authors concluded that CBD "is well tolerated and has relatively few serious adverse effects", but that interactions with other medicines need careful monitoring (Chesney et al., 2020).

Side effects by dose
Side effect Daily dose What was seen
Diarrhoea 10 and 20 mg per kg (epilepsy trials) 13% and 21%, against 10% on placebo. Usually started in the first 6 weeks and lasted a median of 8 days.
Sleepiness, sedation or lethargy 10–25 mg per kg 27–30% overall; 43% with clobazam, 14% without
Reduced appetite, weight loss 10–25 mg per kg Reduced appetite 21%. Weight loss of 5% or more in 21% at 20–25 mg per kg, against 7% at 10 mg per kg.
Raised liver enzymes 5–25 mg per kg See the liver section below

Do side effects happen at food-supplement doses?

This is the honest gap in the research. The large trials used medicine doses: for a 70 kg adult, 10 mg per kg a day is 700 mg of CBD a day. The reference amounts regulators have set for CBD eaten as food are far lower, and there are few good trials at those levels.

What we can say is that diarrhoea, weight loss and liver-enzyme rises became more frequent as the dose went up. The charts show how far apart food reference amounts and trial doses are.

Reference amounts for CBD in food, 70 kg adult (mg a day)

Sources: EFSA 2026 (which also summarises the Swiss recommendation), UK FSA.

Doses used in trials, 70 kg adult (mg a day)

The smallest trial dose is about 30 times the highest food reference amount. Sources: Florian et al. 2025 (5 mg per kg), EMA (10 and 25 mg per kg).

Can CBD affect the liver?

Yes, and this is the side effect regulators take most seriously. CBD is broken down in the liver. At higher doses it can raise the liver enzymes ALT and AST, which doctors use as a warning sign of liver stress.

  • At prescription doses: in the Epidyolex trials, 12% of patients had ALT above three times the normal limit, against under 1% on placebo. The risk was highest with the epilepsy medicine valproate (19–23%) and lowest in patients taking neither valproate nor clobazam (3%). About two-thirds of cases resolved when the dose was lowered or stopped, and about one-third resolved while treatment continued (EMA).
  • In healthy adults: a 2025 placebo-controlled trial gave 5 mg per kg a day for 28 days, a dose chosen because some consumers take that much. 5.6% of the CBD group had liver enzymes above three times the normal limit, against none on placebo. Seven met the criteria for stopping because of possible drug-induced liver injury (Florian et al., 2025).
  • In animal studies: liver changes were the most consistent finding, and EFSA used them as the basis for its provisional safe intake (EFSA, 2026).

Signs of liver problems

If you have a liver condition, drink heavily or take medicines that affect the liver, talk to your doctor before using CBD. Yellowing of the skin or eyes, dark urine, unusual tiredness or pain in the upper right abdomen need medical attention.

Can CBD interact with medication?

Yes. CBD is broken down by the same liver enzymes as many medicines, so it can raise or lower their levels in the blood; in studies, for example, it raised levels of the active breakdown product of the epilepsy medicine clobazam and of the antidepressant citalopram (EMA; Clinical Pharmacology & Therapeutics, 2026). If you take any regular medicine, speak to your doctor or pharmacist first, and see our guide to CBD and medication for which medicines need most caution.

Who should avoid CBD?

Who should avoid CBD, and why
Group Advice Why
Pregnant or trying to conceive Avoid Animal studies show effects on reproduction and development. EFSA notes CBD can cross the placenta. The UK FSA advises avoiding it.
Breastfeeding Avoid No human data on CBD in breast milk. The Epidyolex label advises stopping breastfeeding during treatment.
Children and teenagers Avoid unless prescribed The UK FSA advises under 18s to avoid CBD. EFSA says safety for under 25s can't be established.
People taking medication Ask your doctor first Risk of interactions
People with liver disease Ask your doctor first CBD can raise liver enzymes. Epidyolex needs dose changes in liver impairment.
Before driving Wait until you know how it affects you CBD can cause sleepiness. Full-spectrum oils also contain small amounts of THC.

More on CBD and children, drug tests and driving, and drowsiness in CBD oil and sleep.

What do EFSA and the UK FSA say about CBD?

In February 2026 the European Food Safety Authority (EFSA) updated its 2022 statement on CBD as a novel food. Its expert panel set a provisional safe intake of 0.0275 mg per kg of body weight a day, about 2 mg a day for a 70 kg adult (EFSA Journal, 2026). Three points are easy to miss:

  1. It is a precautionary number. EFSA started from a dose linked to liver changes in 90-day animal studies (11 mg per kg a day) and divided it by 400, because so much data is missing. It isn't a dose at which side effects were seen in people.
  2. It covers pure CBD only. It applies to food supplements with CBD at least 98% pure, without nanoparticles, from a production process judged safe. It doesn't directly assess full-spectrum or broad-spectrum hemp extracts.
  3. It excludes vulnerable groups. EFSA concluded that safety can't be established for people under 25, pregnant or breastfeeding women, or people taking medication.

EFSA also listed what is still unknown: whether CBD builds up in the body with long-term use, how far the liver, reproductive and nervous-system effects seen in animals apply to people, and possible effects on thyroid hormones. No studies have yet looked at effects on the immune system.

The UK Food Standards Agency

Since October 2023 the FSA has advised healthy adults to limit CBD from food to 10 mg a day. It advises children under 18, people taking any medication, and those trying to conceive, pregnant or breastfeeding to avoid CBD unless under medical direction. It adds that "the more CBD you consume over your lifetime, the more likely you are to develop long-term adverse effects, like liver damage or thyroid issues" (FSA consumer advice; restated on the FSA blog, June 2026).

In September 2026 the FSA board recommended that ministers authorise the first CBD foods in England and Wales, with label warnings for under-18s, people who are pregnant, breastfeeding or trying to conceive, and people taking medication or who are immunosuppressed. Ministers make the final decision (FSA board paper, September 2026).

Is CBD safe to use long term?

Nobody knows yet. Most trials last weeks or months, and EFSA says it isn't known whether CBD builds up in the body over time. If you use CBD every day for months, use the lowest amount that suits you and mention it to your doctor at your next check-up.

Could the side effects come from the product rather than the CBD?

Sometimes, yes. A poorly made oil can contain much more THC than stated, a different amount of CBD than the label says, or contaminants. A study published in August 2026 analysed 186 CBD and related oils sold in Europe over about a decade (Binova et al., 2026).

Gas chromatograph with an autosampler tray of sample vials in Formula Swiss's lab
Our lab equipment for measuring cannabinoid content: every production batch is tested before it is sold.
Share of European CBD oils with a problem

Source: Binova et al., Analytical and Bioanalytical Chemistry, 2026.

  • 49% (86 of 181) didn't contain the amount of CBD stated on the label.
  • At the recommended dose, 39% (72 of 186) would exceed EFSA's acute reference dose for THC, 1 µg per kg of body weight. Some also contained other THC variants, and one "full-spectrum" oil contained HHC.
  • Polycyclic aromatic hydrocarbons (PAHs), a group of contaminants, were found in every sample, and 54% were above the EU maximum for oil-based food supplements.

That is why it pays to buy directly from a producer that makes, tests and labels its own oils. At Formula Swiss every production batch is tested, the label shows CBD and THC to two decimal places, and we publish the certificate of analysis. If you need zero THC, choose a THC-free broad-spectrum oil.

Unexpected THC can cause effects people wrongly blame on CBD, such as dizziness, anxiety or a racing heart.

How to check a product before you buy

Look for a certificate of analysis for the exact batch, with CBD and THC stated. Check that the tested CBD matches the label and that the THC result fits the product type, for example 0% for a THC-free oil. A report that also covers contaminants is better.

At Formula Swiss, every production batch is tested, and we publish the certificates of analysis (how we test). To compare THC-free and full-spectrum oils, see full-spectrum or broad-spectrum?

What should I do if I get side effects?

  1. Lower the amount or stop. Most mild effects, such as sleepiness or loose stools, settle when you use less. Our CBD oil dosage guide shows how much CBD is in one drop of each strength.
  2. If CBD makes you sleepy, don't drive.
  3. Stop and see a doctor if you notice signs of liver problems, a rash, or a change in how a medicine works.
  4. Report it. Tell the seller, and report suspected reactions to your national food, cosmetics or medicines authority.

Does CBD have side effects in pets?

Animals process CBD differently from people, so never give a pet an oil made for humans, and ask your vet first. Our guides to CBD for dogs and CBD for cats cover the animal studies and what to watch for.

Frequently asked questions

Does CBD oil have side effects?

Yes. In clinical trials the most common were sleepiness, diarrhoea, reduced appetite and tiredness. At higher doses CBD can raise liver enzymes, and it can interact with some medicines. Effects become more likely as the dose goes up.

Can you overdose on CBD?

Side effects such as sleepiness, diarrhoea and raised liver enzymes become more likely as the amount goes up, even though the WHO's expert committee described CBD as generally well tolerated with a good safety profile (2018). Stay within the label directions, and see a doctor if you feel unwell.

Can CBD cause headaches or dry mouth?

Dry mouth was reported more often with CBD in a two-week insomnia trial of 150 mg a night (Narayan 2025). Headache is not among the most common side effects in the trials summarised above. If either bothers you, use less or stop.

Can CBD damage your liver?

CBD can raise liver enzymes, a sign of liver stress. This was seen in 12% of patients on prescription doses and in 5.6% of healthy adults taking 5 mg/kg a day for four weeks. People with liver disease or on medication should ask a doctor before using CBD.

Can I take CBD while pregnant or breastfeeding?

No. The UK FSA advises avoiding CBD when pregnant, breastfeeding or trying to conceive, and EFSA says its safety in pregnancy and breastfeeding can't be established. Animal studies show reproductive effects.

How much CBD a day is considered safe?

In 2026 EFSA set a provisional safe intake of about 2 mg a day for a 70 kg adult (0.0275 mg/kg), for pure CBD in supplements. The UK FSA advises healthy adults to take no more than 10 mg a day. Both are precautionary levels, not doses at which harm was shown.

Can CBD interact with my medication?

Yes. CBD uses the same liver enzymes as many medicines and can change their blood levels, for example citalopram and the active breakdown product of clobazam. Speak to your doctor or pharmacist before combining CBD with any regular medicine.

Does CBD make you sleepy?

It can. Sleepiness was one of the most common side effects in trials, especially at higher doses and with some medicines. Don't drive until you know how CBD affects you.

Is CBD safe for older people?

Trials haven't looked at older adults specifically. Older people often take several regular medicines, which raises the risk of interactions, so ask your doctor first and start with a low amount.

Could a CBD product contain THC even if the label says otherwise?

Yes. A 2026 European study found that 39% of oils would exceed EFSA's acute THC limit at the recommended dose. Buy from a producer that tests every batch and publishes the certificate of analysis, such as Formula Swiss, and choose THC-free if you need zero THC.

Formula Swiss CBD oils are sold as cosmetics for use on the skin. They are not food supplements or medicines and are not intended to diagnose, treat, cure or prevent any disease. The EFSA and FSA figures in this article are reference amounts for CBD eaten as food. This article is general information and doesn't replace advice from your doctor, pharmacist or vet.

Last reviewed:

Sources

  1. EFSA NDA Panel. Update of the statement on safety of cannabidiol as a novel food. EFSA Journal 2026;24(2). Adopted 16 December 2025, published 9 February 2026. doi:10.2903/j.efsa.2026.9862
  2. European Commission. Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods, consolidated version of 10 August 2026. CELEX 02017R2470-20260810
  3. European Medicines Agency. Epidyolex: summary of product characteristics (PDF).
  4. Florian J, et al. Cannabidiol and liver enzyme level elevations in healthy adults: a randomized clinical trial. JAMA Internal Medicine 2025. doi:10.1001/jamainternmed.2025.2366, PMID 40622698
  5. Chesney E, et al. Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials. Neuropsychopharmacology 2020. doi:10.1038/s41386-020-0667-2
  6. Salcedo P, et al. Clinical study to evaluate drug interactions of cannabidiol with citalopram and morphine in healthy adults. Clinical Pharmacology & Therapeutics 2026. doi:10.1002/cpt.70219, PMID 41622700
  7. World Health Organization, Expert Committee on Drug Dependence. Cannabidiol (CBD): critical review report. 40th meeting, Geneva, June 2018
  8. Narayan AJ, et al. The effect of nightly use of 150 mg cannabidiol on daytime neurocognitive performance in primary insomnia. Psychopharmacology 2025. PMID 39153080
  9. Binova Z, et al. Poorly labeled CBD and related cannabinoid oils marketed in Europe: a hidden risk for consumers? Insights from a long-term study Analytical and Bioanalytical Chemistry 2026. doi:10.1007/s00216-026-06734-5, PMID 42611266
  10. Food Standards Agency. Cannabidiol (CBD): consumer advice. GOV.UK
  11. Food Standards Agency. Food fact check: CBD safety and health claims. FSA blog, 22 June 2026
  12. Food Standards Agency. CBD novel food applications: recommendations to ministers on first authorisations. September 2026
Zurück zum Blog

Hinterlassen Sie einen Kommentar

Bitte beachten Sie, dass Kommentare vor der Veröffentlichung freigegeben werden müssen.

Robin Roy Krigslund-Hansen

Robin Roy Krigslund-Hansen

Über den Autor

Robin Roy Krigslund-Hansen ist Gründer und CEO von Formula Swiss und für die Formulierung verantwortlich. Seit der Gründung des Unternehmens im Jahr 2013 schreibt er über Hanf, CBD und die Cannabisbranche. Seine Sichtweise stützt sich auf den Aufbau von Formula Swiss, Gespräche mit Forschenden und die Förderung der CBD-Forschung.

Mehr über Robin Roy Krigslund-Hansen

Ähnliche Produkte